chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a certified medical assistant concerning 12 patients who on an unknown date were vaccinated with a dose of PNEUMOVAX 23 (Lot number: 663888/0627Y or 662599/1076X). The certified medical assistant reported that the 12 patients had "reactions to PNEUMOVAX 23 ranging from fevers of 102F to 103F and cellulitis." Some patients had "cold like symptoms including muscle aches, fever, cough and congestion, starting the day after the PNEUMOVAX 23 was given". At the time of the report the patient's outcome were not reported. The certified medical assistant stated that 4 patients went to the emergency room and were placed on IV antibiotics but were not admitted to the hospital. The other patients sought medical attention at the physician's office. Follow up information was received from the medical assistant who stated that would like to return PNEUMOVAX 23 that caused patient reactions in the office. Nurse stated "she understands that routine reports had been noted with PNEUMOVAX 23 in the past but had never had reactions such as this in their office". Follow up information has been received from a nurse who reported that a patient who on unknown date was vaccinated with a dose of PNEUMOVAX 23 (Lot number not specified). On an unspecified date, the patient had adverse reactions to PNEUMOVAX 23. This is one of several reports received from the same source.
Severe weakness worsened Myasthenia Gravis. Respiratory muscle weakness, chronic weakness, headaches painful scar tissue. Restlessness unable to sleep. Started 4 day course of IVIG, high dose of prednisone
Same day as injection experienced burning in hand of injected arm.  Next day experienced swollen lymph under injected arm.  Then same hand started intense itching, then peeled.  Also if hand was bumped would bleed easily.  Non injected arm - hand fine.  1 week later and hand feels tender and skin rough.
feel tired with a sore arm; feel tired with a sore arm; he lost smell and taste; he lost smell and taste; woke up sick; faint taste but is unable to smell.; This is a spontaneous report from a contactable consumer or other non hcp(patient).A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,solution for injection,Lot number-not reported),via an unspecified route of administration on 19Jul2021 as DOSE 1, SINGLE for covid-19 immunization.The patient's medical history and concomitant medications were not reported. It was reported that patient received the 1st dose of the Pfizer COVID-19 Vaccine yesterday on 19Jul2021. His symptoms kind of began yesterday and the vaccine provider was aware of them and advised that the patient would feel tired with a sore arm on 20Jul2021.On 19Jul2021 he stated that he has faint taste but was unable to smell. He was calling today to see if loosing taste or anything was normal.He stated that he was not super freaked out or anything.He stated he received his 1st dose of the Pfizer vaccine yesterday and he woke up this morning with common side effects.On 20Jul2021 he stated he lost smell and taste and he doesn't know if that was normal .On 20Jul2021 he stated that he woke up sick on and hasn't been in contact with anyone with Covid.He was asking was this normal.He stated he still has faint taste but he cannot smell anymore.He stated that yesterday he had taken a nap and woke up and noticed that he had lost a little bit of taste and he thought it might be a side effect.He was asking how long it takes to make a report and declines to make a report stating he was looking for information.He clarified it was the Pfizer Covid 19 vaccine.The outcome of all events was unknown.  No follow-up attempts are possible. Information about batch number cannot be obtained.
Swelling not at injection site.  One day after the shot, my right finger swelled up for about 12 hours followed by swelling on the right side of my top and bottom lip.  No treatment, just advised to keep an eye on it.
Patient received the Afluria Flu Vaccine at noon on 11/06/12.  By 4:00 PM he had a rash with hives and a few whelps all over his body from his neck down.  The rash persisted for 2 weeks.  He noticed that it started to fade first on his arms, followed by his chest, and then his legs were the last to resolve.  He never had any itching or discomfort with the rash.  Patient was sent to the Occupational Health physician on 11/09/12.  The Physician attributed the rash to the Afluria flu vaccine. He received no treatment. The physician requested that the manufacturer be contacted to determine the components of the vaccine.  Patient will then need to take this information to his primary care physician.
Information has been received from a LPN concerning a 25 year old female with autoimmune hepatitis who on 09/11/03, was vaccinated with MMRII, SC. Concomitant therapy included six-mercaptopurine for her autoimmune hepatitis. On 09/12/03, the pt experienced peripheral vision abnormalities. The outcome of the peripheral vision abnormalities was not reported. It was unknown whether vaccination with MMRII was related to peripheral vision abnormalities. Unspecified medical attention was sought. No further information is available.
This spontaneous report was received from a nurse practitioner, who was reporting on herself. The patient's pertinent medical history, drug reactions and allergies were not reported. Concomitant therapies were not provided. On 15-MAY-2018, while preparing a dose of M-M-R II (strength, dose, frequency, lot# and expiration date were not reported), the nurse squirted some of the vaccine into her eyes in error. No adverse effects were reported. Product quality complaint (PQC) was not reported.
Shingles: started as pain around lower back, started radiating around my ribs the next day and developed into a rash just under my sternum after 3 days
Pt recv vax on 8/18/97; on 4/1/99 pt exp chicken pox
Patient received vaccine after published expiration date. Moderna Company analyzed lot 007B21A and advised vaccine maintained activity necessary to protect against covid 19  at time vaccine was administered. Patient also did not call in to complain of any adverse events. This is administrative error without adverse event.
pt recv vax 20JUN97 430PM & pt having rash over body & rt leg swollen & sl swelling to lt leg;pt breathing fine;fever & rash;states not eaten anything;dx bronchitis; shot given @ ER for cough & infect;
Approximately 4 hrs after vaccine administration, dark, red, raised rash appeared on torso, arms, buttocks, and legs. So severe that dexamethasone started. Rash did not improve for weeks and steroids continued during that time. Patient noted to then go into congestive heart failure, had 2-3+ pitting edema, "ground glass"/pulmonary congestion in lungs, rapid A-fib with RVR 170-180s. treated at Hospital with admission from 5/15-5/17/2021. Patient complained of chest pain and trouble breathing starting 5/13/2021. Patient has mostly recovered, and is at home now. Now on high dose beta-blockers and eliquis for the new onset A-Fib.
10/19/14 Head/chest congestion, Facial edema in cheeks and around eyes - Blurred vision in both eyes.
Swollen lymph node; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 26Mar2021 (Batch/Lot number: unknown) at the age of 47 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Environmental Allergies" (unspecified if ongoing), notes: Environmental Allergies; "GERD" (unspecified if ongoing); "HTN" (unspecified if ongoing), notes: HTN; "allergies: Sulfa" (unspecified if ongoing), notes: known allergies: Sulfa. Concomitant medication(s) included: PANTOPRAZOLE; PREDNISONE; PHENTERMINE. Past drug history included: Nasonex, reaction(s): "allergies: nasonex", notes: known allergies: nasonex; Omnaris, reaction(s): "allergies: omnaris", notes: known allergies: omnaris. Vaccination history included: Bnt162b2 (product= COVID 19,, lot unknown reason= Other,, lot unknown reason other= Public health event,, administration time= 03:15 PM,, vaccine location= Left arm,, dose number= 1, Cellulitis- 10 days (10Mar21) following first dose on 26Feb21), administration date: 26Feb2021, when the patient was 47 years old, for Covid-19 Immunization, reaction(s): "Cellulitis". The following information was reported: LYMPHADENOPATHY (non-serious) with onset 2021, outcome "recovered" (2021), described as "Swollen lymph node". The event "swollen lymph node" was evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (27Mar2021) negative, notes: Nasal swab. Therapeutic measures were taken as a result of lymphadenopathy.  Additional information: It was reported that the patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and Since the vaccination, the patient had been tested for COVID-19. It was reported that patient had received Pantoprazalol, prednisone, phenteromine, and more medications within 2 weeks of vaccination. Patient had received treatment of Keflex then Doxycycline. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
a severe Headache with Fever; a severe Headache with Fever; Initial information received on 30-Jul-2019 regarding an unsolicited valid non-serious case received from a physician.  This case is linked to case 2019SA209485.  This case involves an 11 years old male patient who experienced a severe headache with fever, while he received vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE (HPV VACCINE); and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP).  On 27-Jul-2019, the patient received a dose of suspect 0.5 ml MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot U6522AB and expiry date: 29-Jan-2021 via unknown route in the left deltoid.  On an unknown date, following the vaccination the patient experienced fever (pyrexia) and headache.  Relevant laboratory test results included: Full blood count - On an unknown date: [increase in WBC]  (Other relevant tests included no lab data.)  Final diagnosis was fever and severe headache.  The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]).  The outcome of the events was reported as unknown at the time of reporting.  List of documents held by sender: none.
got one dose of shingrix on july 31; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles in March). Previously administered products included Shingrix (1st dose received on 31st July).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not applicable to this report. The patient received 1st dose of Shingrix on 31th July. Till the time of reporting, the patient did not receive 2nd dose, which led to incomplete course of vaccination. The patient asked if he/she could take the second dose now or if he/she needed to start over. The follow-up would not possible, as no contact, details were available.
The 1st day of vaccine I started to feel tingling in my whole body, difficulty  walking , very bad balanced, Brain fog, numbness, sever pain, Fatigue, my head and feet would twitch  I had a xray of my back no problem that would cause the tingling. the RA Dr referred me to the Neurologist  who saw me at the beginning of April she ran large amount of blood work, I had a MRI and there were no signs of a problem . The Neurologist didn't do any more testing after the MRI because my symptoms went away. I had taken a steroid a few weeks before seeing the Neurologist for my result for the RA flare up and the symptoms went away.
Didn't feel well; Felt like been run over by a truck, just wiped out; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel well) and FATIGUE (Felt like been run over by a truck, just wiped out) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Didn't feel well) and FATIGUE (Felt like been run over by a truck, just wiped out). At the time of the report, MALAISE (Didn't feel well) and FATIGUE (Felt like been run over by a truck, just wiped out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MOD-2021-072998, MOD-2021-072998.   Reporter did not allow further contact
CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; TESTED POSITIVE FOR COVID; This spontaneous report received from a patient concerned an elderly male of unspecified Ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, 1 total dose administered on 12-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 22-MAR-2021, the patient had antigen test and he was tested positive for covid. On 22-May-2021 he had antibody test and result was negative (confirmed immunological vaccine failure). He was afraid of getting infected once again as he was old and the vaccine did not produce antibodies. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tested positive for covid and confirmed immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000181111.; Sender's Comments: V0. 20210556637-COVID-19 VACCINE AD26.COV2.S. Confirmed immunological vaccine failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
I woke up early in the morning with night sweats at 2:30am, this continued for thirty-five days. I took a home COVID-19 test that came back negative. I made an appointment with my doctor who ordered CT scans. They did not show any cause for the night sweats that I was having. We have not found what caused the night sweats, they have gone the fatigue lingered for a while but it is gone now.
12 minutes, first vaccine reported tingling to the tongue, cheeks flushed, progression to feeling like throat was swelling. Patient was taken to ED via wheelchair. Monitoring and BP @7:40 135/83 HR 72 Resp. 18. Under oBS at hospital, not admitted.  *Initial dose reported symptoms of feeling sick with dose 1 but not to extent of second dose
I was preparing Pfizer COVID-19 for administration. After adding the diluent to vile, I started drawing-up the doses in syringes. Due to the pressure in the vile, while drawing up the dose the vile sprayed me in both eyes. I finished drawing up all doses from that vile and went to the restroom to rinse out my eyes.
I was diagnosed with Bell?s Palsy on the left side of my face one week after I received my second moderna shot.
Big knot at needle shot sight; Stiffness; Could not sleep; Heavy head; Restless; flu like symptoms; No Appetite; bodyaches; muscle achiness; Low grade 99.9 fever; chills; warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big knot at needle shot sight), MUSCULOSKELETAL STIFFNESS (Stiffness), INSOMNIA (Could not sleep), HEAD DISCOMFORT (Heavy head) and RESTLESSNESS (Restless) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Patient allergic to Demoral). Concomitant products included ESTRADIOL from 08-Mar-2020 to an unknown date and ALENDRONATE SODIUM from 03-Jan-2018 to an unknown date for an unknown indication.   On 02-Mar-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE MASS (Big knot at needle shot sight), MUSCULOSKELETAL STIFFNESS (Stiffness), INSOMNIA (Could not sleep), HEAD DISCOMFORT (Heavy head), RESTLESSNESS (Restless), PAIN (bodyaches) and PYREXIA (Low grade 99.9 fever). 02-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (No Appetite), MYALGIA (muscle achiness), CHILLS (chills) and FEELING HOT (warm). At the time of the report, VACCINATION SITE MASS (Big knot at needle shot sight), MUSCULOSKELETAL STIFFNESS (Stiffness), INSOMNIA (Could not sleep), HEAD DISCOMFORT (Heavy head), RESTLESSNESS (Restless), INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (No Appetite), PAIN (bodyaches), PYREXIA (Low grade 99.9 fever), CHILLS (chills) and FEELING HOT (warm) had resolved and MYALGIA (muscle achiness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Body temperature: 99.9 (Inconclusive) N/A.         Treatment medication was not provided. Patient states that symptoms went away on the next day. Patient height provided as 5 with no units.   This case was linked to MOD-2021-268006 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Updated patient demographers, allergic condition, concomitant medications,  events include-chills, low grade fever, flue like symptoms, body aches, no appetite.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
redness, injection site is raised, itchy and warm to the touch. Took Benadryl
Developed an area of erythema on right upper arm about 10x7cm.  Non tenderness or swelling.
Red area had increased from about 1/4 of an inch in diameter to approximately 2 and 3/4 of an inch in diameter; It is slightly warm to the touch with slight itching if touched by clothing, but is not bothering me; It is slightly warm to the touch with slight itching if touched by clothing, but is not bothering me; Minor soreness and redness at injection site; Minor soreness and redness at injection site; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received first dose of BNT162B2 (Covid shot, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EL3247; NDC number; Expiry Date: Unknown), via left arm on 03Feb2021 at (dose number 1) single dose for COVID-19 immunisation. Medical history included joint area sore (stated have pre-existing condition with left shoulder that can make joint area sore so that may have masked earlier discovery) from an unknown date. Concomitant medication included vitamin D3. The patient described the red area had increased from about 1/4 of an inch in diameter to approximately 2 and 3/4 of an inch in diameter and It was slightly warm to the touch with slight itching if touched by clothing, but was not bothering him on 06Feb2021. He looked for guidance on the CDC website and it said to contact your PCP if the redness or tenderness where you got the shot increases after 24 hours. He notified his PCP via the non-urgent messaging application in the patient portal shortly after making the discovery and getting guidance. Otherwise, He felt fine. Minor soreness and redness at injection site discovered on 04Feb2021 while trying to remove bandage. He did not receive any treatment for events. The patient did not had covid prior vaccination and not had covid tested post vaccination. The outcome of all events were Recovering.
Employee received the Pfizer vaccine dose #3 on 08/20 at the TCH main campus PFW vaccine event. The injection was in the righter upper arm in deltoid. Started have symptoms couple hours of vaccination: body aches, fever, chills, and upset stomach. Has been off of work since 08/20;day of vaccination. The symptoms have improved on 8/22.
14 days post 2nd dose of Pfizer mRNA vaccine itchiness; 38 days shoulder triceps area shingles breakout.; 17 days pain; This is a spontaneous report from a contactable physician via a sales representative.   A 65-year-old male patient received second dose of bnt162, (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as second dose single dose for covid-19 immunisation. Medical history included herpes zoster from an unknown date and unknown if ongoing treated with valacyclovir and gabapentin. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as first dose single dose for covid-19 immunisation. The patient experienced 14 days post 2nd dose of Pfizer mrna vaccine itchiness, 38 days shoulder triceps area shingles breakout and 17 days pain. Included in medical journal letter accepted in May. The patient underwent lab tests and procedures which included varicella virus test: positive on unspecified date. Therapeutic measures were taken valacyclovir, gabapentin, as a result of the events itchiness and shingles and no treatment received for pain. The outcome of the events was reported as recovered.  Information about lot/batch number is requested.
Light head, oral & generalized itching feeling flushed  25mg Benadryl PO - Resolved Sx
syncope for 2-3 seconds, hit head on ground. symptoms improved after laying down.
I developed a morbilliform, pustular rash 48 hours after the first injection of the Pfizer COVID-19 vaccine.  The rash consists of pustules on an erythematous base on the ventral surface of both arms.  It is mildly pruritic.  It is not painful.  I have no other associated symptoms and feel otherwise fine. I took ibuprofen 600 mg 24 hours ago.  I have never had a vaccine reaction before.   A dermatologist has seen pictures of the rash and thinks it is likely acute generalized Exanthemata's Pustulosis. Employee health has been notified.
Palpitations started  mid June and weren?t bad but by July they were often - sometimes every 3 or four beats. On 7/26 I saw a cardiologist and had ekg echo and wore a 24 hour monitor .  By end of August they completely resolved